Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
Add more filters










Publication year range
1.
Behav Brain Res ; 238: 146-53, 2013 Feb 01.
Article in English | MEDLINE | ID: mdl-23103401

ABSTRACT

Social isolation of rodents (SI) elicits a variety of stress responses such as increased aggressiveness, hyper-locomotion, and reduced susceptibility to pentobarbital. To obtain a better understanding of the relevance of SI-induced behavioral abnormalities to psychiatric disorders, we examined the effect of SI on latent learning as an index of spatial attention, and discussed the availability of SI as an epigenetic model of attention deficit hyperactivity disorder (ADHD). Except in specially stated cases, 4-week-old male mice were housed in a group or socially isolated for 3-70 days before experiments. The animals socially isolated for 1 week or more exhibited spatial attention deficit in the water-finding test. Re-socialized rearing for 5 weeks after 1-week SI failed to attenuate the spatial attention deficit. The effect of SI on spatial attention showed no gender difference or correlation with increased aggressive behavior. Moreover, SI had no effect on cognitive performance elucidated in a modified Y-maze or an object recognition test, but it significantly impaired contextual and conditional fear memory elucidated in the fear-conditioning test. Drugs used for ADHD therapy, methylphenidate (1-10 mg/kg, i.p.) and caffeine (0.5-1 mg/kg, i.p.), improved SI-induced latent learning deficit in a manner reversible with cholinergic but not dopaminergic antagonists. Considering the behavioral features of SI mice together with their susceptibility to ADHD drugs, the present findings suggest that SI provides an epigenetic animal model of ADHD and that central cholinergic systems play a role in the effect of methylphenidate on SI-induced spatial attention deficit.


Subject(s)
Attention Deficit Disorder with Hyperactivity/psychology , Attention/physiology , Learning/physiology , Social Isolation , Spatial Behavior/physiology , Aggression/drug effects , Animals , Attention/drug effects , Caffeine/pharmacology , Central Nervous System Stimulants/pharmacology , Disease Models, Animal , Fear/drug effects , Fear/physiology , Female , Learning/drug effects , Male , Methylphenidate/pharmacology , Mice , Mice, Inbred ICR , Motor Activity/drug effects , Recognition, Psychology/drug effects , Recognition, Psychology/physiology , Spatial Behavior/drug effects
2.
Neurosci Res ; 73(3): 257-62, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22542571

ABSTRACT

Social isolation stress induces behavioral disturbances such as aggression, cognitive impairments, and deficits in prepulse inhibition in mice. Social isolation mice have, therefore, been studied as an animal model of neuropsychiatric disorders such as schizophrenia. Recently, the decrease in early growth response (Egr) gene expression levels were reported in the post-mortem brains of schizophrenia patients. In this study, we investigate the effects of social isolation stress on the expression levels of Egr mRNA and protein in the frontal cortex. Social isolation stress exposure significantly down-regulated the expression of Egr-1 protein and Egr-1 gene transcript in nucleus of cortical neurons in a manner dependent on a social isolation period. This stress had no effect on the expression level of Egr-1 in the striatum or the expression levels of other Egr family members (Egr-2, -3, and -4) in the frontal cortex. These results suggest that the decrease in Egr-1 expression in the frontal cortex may be involved in social isolation stress-induced behavioral abnormalities.


Subject(s)
Behavior, Animal/physiology , Early Growth Response Protein 1/biosynthesis , Neurocognitive Disorders/genetics , Social Isolation , Stress, Psychological/genetics , Animals , Disease Models, Animal , Down-Regulation/genetics , Early Growth Response Protein 1/antagonists & inhibitors , Early Growth Response Protein 1/genetics , Frontal Lobe/metabolism , Frontal Lobe/physiopathology , Male , Mice , Mice, Inbred ICR , Neurocognitive Disorders/metabolism , Neurocognitive Disorders/physiopathology , Social Isolation/psychology , Stress, Psychological/metabolism , Stress, Psychological/physiopathology
3.
Biol Pharm Bull ; 33(4): 636-40, 2010.
Article in English | MEDLINE | ID: mdl-20410598

ABSTRACT

The aim of this study was to examine gene expression changes in the frontal cortex and hippocampus of animals with different susceptibility to stressful stimuli. Using a learned helplessness (LH) paradigm, mice received moderate current stimulation to induce different extents of LH behavior. Changes in mRNA expression were investigated by microarray and semiquantitative reverse transcription-polymerase chain reaction (RT-PCR). Comparisons of expression profiles between LH and control or non-learned helplessness (non-LH) animals revealed that the signal transducers and activators of transcription 3 (Stat3)-interacting protein (StIP1) gene is downregulated in LH animals and the suppressor of cytokine signaling 3 (Socs3) gene is up-regulated in non-LH animals. Since both StIP1 and Socs3 regulate the activity of Stat3 gene, these results suggest that Stat3 systems may be involved in the pathogenesis of depressive disorders.


Subject(s)
Brain/metabolism , Depression/genetics , Gene Expression , Helplessness, Learned , STAT3 Transcription Factor/genetics , Signal Transduction/genetics , Animals , Depression/etiology , Disease Models, Animal , Genes , Genetic Predisposition to Disease , Male , Mice , Mice, Inbred ICR , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , STAT3 Transcription Factor/metabolism , Suppressor of Cytokine Signaling Proteins/genetics , Suppressor of Cytokine Signaling Proteins/metabolism , Transcriptional Activation
4.
Biol Pharm Bull ; 33(1): 53-7, 2010.
Article in English | MEDLINE | ID: mdl-20045935

ABSTRACT

We previously reported that long-term treatment with some antidepressants at low concentrations upregulates BCL2/adenovirus E1B 19-kDa-interacting protein 3 (BNIP3) mRNA expression in NG108-15 cells without causing cell damage, suggesting that BNIP3 is a candidate of intrinsic depressive disorder-related factor(s). In this study, to clarify the physiologic functions of BNIP3, we investigated whether BNIP3 is actually related to the depressive condition in the brain using learned helplessness (LH) mice, an animal model of depression. Based on the score of escape failure, an index of depression degree, stressed animals were divided into groups with LH and without depressive-like symptoms (i.e., non-depressed phenotype, non-LH). The score of escape failure of the LH group was decreased after 14 d of treatment with imipramine in a dose-dependent manner. BNIP3 mRNA expression was enhanced in both the LH and non-LH groups. Imipramine treatment at 5 and 20 mg/kg/d enhanced BNIP3 mRNA expression only in the LH group but not in non-LH group or non-stressed group. These results raise the possibility that BNIP3 acts as an antistress factor in the brain.


Subject(s)
Adaptation, Physiological , Antidepressive Agents, Tricyclic/pharmacology , Frontal Lobe/drug effects , Imipramine/pharmacology , Membrane Proteins/metabolism , Mitochondrial Proteins/metabolism , Stress, Psychological/metabolism , Adaptation, Physiological/genetics , Animals , Antidepressive Agents, Tricyclic/therapeutic use , Depression/drug therapy , Depression/genetics , Depression/metabolism , Dose-Response Relationship, Drug , Frontal Lobe/metabolism , Helplessness, Learned , Imipramine/therapeutic use , Male , Membrane Proteins/genetics , Mice , Mice, Inbred ICR , Mitochondrial Proteins/genetics , Models, Animal , RNA, Messenger/metabolism , Stress, Psychological/drug therapy , Stress, Psychological/genetics , Up-Regulation
5.
Biol Pharm Bull ; 32(1): 79-85, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19122285

ABSTRACT

In this study we elucidated the effects of berberine, a major alkaloid component contained in medicinal herbs, such as Phellodendri Cortex and Coptidis Rhizoma, on ischemic neuronal damage in mouse organotypic hippocampal slice cultures (OHSCs) caused by oxygen and glucose deprivation (OGD) and N-methyl-D-aspartate (NMDA) -type glutamate receptor stimulation. Hippocampal slices obtained from 7-d-old ICR mice were cultured for 10 d before the experiments. Ischemia-related damage was induced by OGD (5, 15, 45 min) or NMDA (10 microM) treatment, and was evaluated by measuring propidium iodide (PI) uptake. Levels of apoptotic marker proteins, B-cell lymphoma 2 (Bcl-2) and phosphorylated-Bcl-2 (p-Bcl-2), in the OHSCs were measured as indices of biochemical neuronal cell damage by Western blotting. Berberine (5, 25 microM) or the NMDA antagonist MK-801 (25 microM) was added to the medium 30 min before OGD or NMDA treatment. OGD time-dependently increased PI uptake of the OHSCs. Both berberine (5, 25 microM) and MK-801 (25 microM) significantly inhibited PI uptake at 24 h after 45-min OGD treatment and PI uptake in OHSCs exposed to NMDA for 24 h. OGD treatment also significantly increased the level of p-Bcl-2 but not that of Bcl-2 or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in OHSCs. Berberine (5-25 microM) significantly suppressed the OGD-induced increase of p-Bcl-2 level in OHSCs when tissue was exposed to the alkaloid prior to OGD or simultaneously with OGD. These findings suggest that berberine has protective effects against ischemic damage in mouse OHSCs and that the effects are at least partly mediated by suppression of Bcl-2 phosphorylation.


Subject(s)
Berberine/chemistry , Berberine/pharmacology , Docosahexaenoic Acids/pharmacology , Hippocampus/pathology , Neurons/drug effects , Animals , Berberine/therapeutic use , Cell Death/drug effects , Docosahexaenoic Acids/therapeutic use , Excitatory Amino Acid Agonists/pharmacology , Glucose/deficiency , Hippocampus/drug effects , Hippocampus/physiopathology , Hypoxia/complications , Hypoxia/drug therapy , Ischemia/complications , Ischemia/pathology , Isoxazoles/pharmacology , Isoxazoles/therapeutic use , Mice , Mice, Inbred ICR , N-Methylaspartate/pharmacology , Organ Culture Techniques , Phosphorylation , Propidium , Proto-Oncogene Proteins c-bcl-2/metabolism , Sulfonamides/pharmacology , Sulfonamides/therapeutic use , Time Factors
6.
Biol Pharm Bull ; 30(12): 2250-6, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18057707

ABSTRACT

Macrophage colony stimulating factor (M-CSF) is a cytokine which has been recently reported to have a neuroprotective effect on ischemic rat brain. In this study, we investigated the effect of chotosan, an oriental medicine, which has been clinically demonstrated to be effective for the treatment of vascular dementia, on M-CSF gene expression in rats with permanent occlusion of bilateral common carotid arteries (P2VO) in vivo and in a C6Bu-1 glioma cell line in vitro. The expression level of M-CSF mRNA in the cerebral cortices of P2VO rats was significantly higher than that in the cerebral cortices of sham-operated animals. Repeated treatment of P2VO rats with chotosan (75 mg/kg per day) for 4 d after P2VO significantly increased the expression level of M-CSF mRNA in the cortex but it had no effect on the expression of beta-actin, granulocyte colony stimulating factor (G-CSF), granulocyte/macrophage colony stimulating factor (GM-CSF) mRNAs. Moreover, the present in vitro studies revealed that chotosan treatment (10-100 mug/ml) of C6Bu-1 glioma cells dose-dependently enhanced M-CSF mRNA expression without affecting the expression of G-CSF, GM-CSF, and inducible nitric oxide synthase mRNAs. The effect of chotosan was reversed by Ro 31-8220 (1 muM), a selective protein kinase C (PKC) inhibitor, but not by H-89 (10 muM), a selective protein kinase A (PKA) inhibitor. These findings suggest that the upregulatory effect of chotosan on M-CSF mRNA expression involves PKC and may play an important role in the anti-vascular dementia action of this formula.


Subject(s)
Brain Chemistry/drug effects , Brain Ischemia/metabolism , Brain Neoplasms/metabolism , Drugs, Chinese Herbal/pharmacology , Glioma/metabolism , Macrophage Colony-Stimulating Factor/antagonists & inhibitors , Macrophage Colony-Stimulating Factor/biosynthesis , RNA, Messenger/biosynthesis , Animals , Carotid Artery, Common/physiology , Carotid Stenosis/physiopathology , Cell Line, Tumor , Cell Survival/drug effects , Male , Protein Kinase C/physiology , Rats , Rats, Wistar , Receptors, Colony-Stimulating Factor/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/physiology , Tetrazolium Salts , Thiazoles
7.
Biol Pharm Bull ; 30(9): 1732-9, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17827730

ABSTRACT

This study aimed to investigate the mechanism underlying the protective effects of manganese complexes of curcumin (Cp-Mn) and diacetylcurcumin (DiAc-Cp-Mn) on kainic acid (KA)-induced excitotoxicity in the rat hippocampus. Systemic injection of KA (10 mg/kg, i.p.) caused seizures and increased the expression of neurotoxic markers, immediate early genes [c-jun, cyclooxygenase 2 (COX-2), brain-derived neurotrophic factor (BDNF), and heat shock protein 70 (hsp70)] and a delayed response gene [inducible nitric oxide synthase (iNOS)], which were measured at 6 and 72 h after KA injection, respectively, in the hippocampus. Pretreatment with Cp-Mn (50 mg/kg, i.p.) and DiAc-Cp-Mn (50 mg/kg, i.p.) but not with curcumin (50 mg/kg, i.p.) delayed the onset of KA-induced seizure without affecting the seizure score. KA injection induced c-Fos immunoreactivity in DG, CA1, and CA3 hippocampal regions, the expression of which peaked at 6 h after injection. Cp-Mn and DiAc-Cp-Mn treatment significantly decreased c-Fos expression elicited by KA. Moreover, Cp-Mn and DiAc-Cp-Mn administration suppressed the KA-induced expression of c-jun, COX-2, BDNF, and iNOS mRNA, whereas curcumin attenuated only iNOS mRNA expression. No compounds tested had an effect on KA-induced hsp70 expression. It is therefore likely that in addition to radical scavenging and SOD-like activities, the suppression of potential neuronal injury marker expression by Cp-Mn and DiAc-Cp-Mn, contributes to the neuroprotective activities of these compounds, which are superior to those of curcumin, on KA-induced excitotoxicity in the hippocampus. These results suggest the beneficial effects of Cp-Mn, and DiAc-Cp-Mn on the treatment of excitotoxicity-induced neurodegenerative diseases.


Subject(s)
Curcumin/analogs & derivatives , Excitatory Amino Acid Agonists/toxicity , Hippocampus/pathology , Kainic Acid/antagonists & inhibitors , Kainic Acid/toxicity , Manganese/pharmacology , Neurotoxicity Syndromes/prevention & control , Animals , Behavior, Animal/drug effects , Brain-Derived Neurotrophic Factor/biosynthesis , Cell Death/drug effects , Curcumin/pharmacology , Cyclooxygenase 2/metabolism , HSP70 Heat-Shock Proteins/biosynthesis , Immunohistochemistry , Male , Neurons/drug effects , Neurons/pathology , Nitric Oxide Synthase Type II/biosynthesis , Proto-Oncogene Proteins c-fos/biosynthesis , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Seizures/chemically induced , Seizures/prevention & control
8.
J Pharmacol Sci ; 103(4): 360-73, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17409635

ABSTRACT

We previously demonstrated that the Kampo formula chotosan (CTS) ameliorated spatial cognitive impairment via central cholinergic systems in a chronic cerebral hypoperfusion (P2VO) mouse model. In this study, the object discrimination tasks were used to determine if the ameliorative effects of CTS on P2VO-induced cognitive deficits are a characteristic pharmacological profile of this formula, with the aim of clarifying the mechanisms by which CTS enhances central cholinergic function in P2VO mice. The cholinesterase inhibitor tacrine (THA) and Kampo formula saikokeishito (SKT) were used as controls. P2VO impaired object discrimination performance in the object recognition, location, and context tests. Daily administration of CTS (750 mg/kg, p.o.) and THA (2.5 mg/kg, i.p.) improved the object discrimination deficits, whereas SKT (750 mg/kg, p.o.) did not. In ex vivo assays, tacrine but not CTS or SKT inhibited cortical cholinesterase activity. P2VO reduced the mRNA expression of m(3) and m(5) muscarinic receptors and choline acetyltransferase but not that of other muscarinic receptor subtypes in the cerebral cortex. Daily administration of CTS and THA but not SKT reversed these expression changes. These results suggest that CTS and THA improve P2VO-induced cognitive impairment by normalizing the deficit of central cholinergic systems and that the beneficial effect on P2VO-induced cognitive deficits is a distinctive pharmacological characteristic of CTS.


Subject(s)
Cholinergic Fibers/drug effects , Cognition Disorders/prevention & control , Drugs, Chinese Herbal/pharmacology , Recognition, Psychology/drug effects , Acetylcholinesterase/genetics , Actins/genetics , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Brain Ischemia/complications , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebrovascular Circulation/drug effects , Choline O-Acetyltransferase/genetics , Cholinergic Fibers/pathology , Cholinesterase Inhibitors/pharmacology , Chronic Disease , Cognition Disorders/etiology , Discrimination, Psychological/drug effects , Exploratory Behavior/drug effects , Male , Medicine, Kampo , Mice , Mice, Inbred ICR , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Muscarinic/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tacrine/pharmacology
9.
Pharmacol Biochem Behav ; 85(2): 324-31, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17034840

ABSTRACT

To better understand neurochemical and psychopharmacological aspects of post-traumatic stress disorder (PTSD), it is necessary establish an animal model of PTSD in which behavioral changes persist for a long time after the initial traumatization. The present study aimed to characterize long-term behavioral alterations in male ICR mice as an animal model of PTSD consisting of a 2-day foot shock (0.8 mA, 10 s) followed by 3 weekly situational reminders (SR), and to evaluate the effects of repeated administration of valproate and diazepam on behavioral deficits of this animal model. The results showed that the aversive procedure induced several long-term behavioral deficiencies: increased freezing behavior and anxiety level, reduced time spent in an aversive like context. Repeated treatment with valproate (100-400 mg/kg, i.p.) induced a dose-dependent reduction of these behavioral changes. In contrast, diazepam at a low dose (0.25 mg/kg) but not at a high dose (4 mg/kg) reduced the behavioral deficiencies. These results demonstrate that exposure to intense foot shock associated with repeated situational reminders elicits long-term disturbances that last about 4 weeks after the foot shock exposure. These behavioral deficits can be ameliorated by repeated administration of valproate or diazepam at some special dose ranges.


Subject(s)
Diazepam/therapeutic use , Stress Disorders, Post-Traumatic/drug therapy , Valproic Acid/therapeutic use , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Male , Maze Learning/drug effects , Mice , Mice, Inbred ICR , Motor Activity/drug effects , Stress Disorders, Post-Traumatic/psychology
10.
Free Radic Res ; 40(7): 685-95, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16983995

ABSTRACT

N(alpha)-vanillyl-N(omega)-nitroarginine (N - 1) that combines the active functions of natural antioxidant and nitric oxide synthase inhibitor was developed for its neuroprotective properties. N - 1 exhibited protective effects against hydrogen peroxide-induced cell damage and the inhibitory effect on nitric oxide 'NO' production induced by calcium ionophore in NG 108-15 cells. N - 1 inhibited the constitutive NOS isolated from rat cerebellar in a greater extent than constitutive NOS from human endothelial cells. Low binding energy (-10.2 kcal/mol) obtained from docking N - 1 to nNOS supported the additional mode of action of N - 1 as an nNOS inhibitor. The in vivo neuroprotective effect on kainic acid-induced nitric oxide production and neuronal cell death in rat brain was investigated via microdialysis. Rats were injected intra-peritonially with N - 1 at 75 micromol/kg before kainic acid injection (10 mg/kg). The significant suppression effect on kainic acid-induced NO and significant increase in surviving cells were observed in the hippocampus at 40 min after the induction.


Subject(s)
Antioxidants/pharmacology , Brain/drug effects , Enzyme Inhibitors/pharmacology , Neuroprotective Agents/pharmacology , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type I/antagonists & inhibitors , Nitroarginine/analogs & derivatives , Animals , Antioxidants/chemical synthesis , Antioxidants/chemistry , Antioxidants/metabolism , Brain/cytology , Brain/metabolism , Cell Death/drug effects , Cell Line, Tumor , Endothelial Cells/metabolism , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/metabolism , Humans , Hydrogen Peroxide/pharmacology , Kainic Acid/pharmacology , Male , Mice , Models, Molecular , Neurons/cytology , Neurons/drug effects , Neuroprotective Agents/chemical synthesis , Neuroprotective Agents/chemistry , Neuroprotective Agents/metabolism , Nitric Oxide/metabolism , Nitric Oxide Synthase Type I/metabolism , Nitric Oxide Synthase Type III/metabolism , Nitroarginine/chemical synthesis , Nitroarginine/pharmacology , Rats , Rats, Wistar
11.
Pharmacol Biochem Behav ; 83(2): 186-93, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16519925

ABSTRACT

Increasing evidences indicate the concurrence and interrelationship of depression and cognitive impairments. The present study was undertaken to investigate the effects of two depressive animal models, learned helplessness (LH) and chronic mild stress (CMS), on the cognitive functions of mice in the Morris water maze task. Our results demonstrated that both LH and CMS significantly decreased the cognitive performance of stressed mice in the water maze task. The escaping latency to the platform was prolonged and the probe test percentage in the platform quadrant was reduced. These two models also increased the plasma corticosterone concentration and decreased the brain derived neurotrophic factor (BDNF) and cAMP-response element-biding protein (CREB) messenger ribonucleic acid (mRNA) levels in hippocampus, which might cause the spatial cognition deficits. Repeated treatment with antidepressant drugs, imipramine (Imi) and fluoxetine (Flu), significantly reduced the plasma corticosterone concentration and enhanced the BDNF and CREB levels. Furthermore, antidepressant treated animals showed an ameliorated cognitive performance compared with the vehicle treated stressed animals. These data suggest that both LH and CMS impair the spatial cognitive function and repeated treatment with antidepressant drugs decreases the prevalence of cognitive impairments induced by these two animal models. Those might in part be attributed to the reduced plasma corticosterone and enhanced hippocampal BDNF and CREB expressions. This study provided a better understanding of molecular mechanisms underlying interactions of depression and cognitive impairments, although animal models used in this study can mimic only some aspects of depression or cognition of human.


Subject(s)
Learning/drug effects , Memory/drug effects , Stress, Physiological/physiopathology , Animals , Base Sequence , Brain-Derived Neurotrophic Factor/genetics , Chronic Disease , Corticosterone/blood , Cyclic AMP Response Element-Binding Protein/genetics , DNA Primers , Fluoxetine/pharmacology , Imipramine/pharmacology , Male , Mice , Mice, Inbred ICR , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction
12.
Life Sci ; 78(16): 1884-91, 2006 Mar 13.
Article in English | MEDLINE | ID: mdl-16266725

ABSTRACT

Curcumin is a natural antioxidant isolated from the medicinal plant Curcuma longa Linn. We previously reported that manganese complexes of curcumin (Cp-Mn) and diacetylcurcumin (DiAc-Cp-Mn) exhibited potent superoxide dismutase (SOD)-like activity in an in vitro assay. Nitric oxide (NO) is a free radial playing a multifaceted role in the brain and its excessive production is known to induce neurotoxicity. Here, we examined the in vivo effect of Cp-Mn and DiAc-Cp-Mn on NO levels enhanced by kainic acid (KA) and L-arginine (L-Arg) in the hippocampi of awake rats using a microdialysis technique. Injection of KA (10 mg/kg, i.p.) and L-Arg (1000 mg/kg, i.p.) significantly increased the concentration of NO and Cp-Mn and DiAc-Cp-Mn (50 mg/kg, i.p.) significantly reversed the effects of KA and L-Arg without affecting the basal NO concentration. Following KA-induced seizures, severe neuronal cell damage was observed in the CA1 and CA3 subfields of hippocampal 3 days after KA administration. Pretreatment with Cp-Mn and DiAc-Cp-Mn (50 mg/kg, i.p.) significantly attenuated KA-induced neuronal cell death in both CA1 and CA3 regions of rat hippocampus compared with vehicle control, and Cp-Mn and DiAc-Cp-Mn showed more potent neuroprotective effect than their parent compounds, curcumin and diacetylcurcumin. These results suggest that Cp-Mn and DiAc-Cp-Mn protect against KA-induced neuronal cell death by suppression of KA-induced increase in NO levels probably by their NO scavenging activity and antioxidative activity. Cp-Mn and DiAc-Cp-Mn have an advantage to be neuroprotective agents in the treatment of acute brain pathologies associated with NO-induced neurotoxicity and oxidative stress-induced neuronal damage such as epilepsy, stroke and traumatic brain injury.


Subject(s)
Apoptosis/drug effects , Excitatory Amino Acid Agonists/toxicity , Hippocampus/drug effects , Kainic Acid/toxicity , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Nitric Oxide/metabolism , Animals , Arginine/pharmacology , Curcumin/analogs & derivatives , Curcumin/chemistry , Curcumin/therapeutic use , Hippocampus/metabolism , Male , Manganese/chemistry , Manganese/therapeutic use , Neurons/metabolism , Neurons/pathology , Oxidative Stress , Rats , Rats, Wistar , Seizures/chemically induced , Seizures/metabolism , Seizures/prevention & control
13.
Biol Pharm Bull ; 28(12): 2231-4, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16327155

ABSTRACT

The effects of acacetin (1) and 4,5-O-dicaffeoylquinic acid methyl ester (2), compounds contained in the flowers of Chrysanthemum sinense SABINE, on the serum uric acid level were investigated using the rats pretreated with the uricase inhibitor potassium oxonate as an animal model for hyperuricemia. When administered per orally at doses of 20 and 50 mg/kg, 1 reduced the serum uric acid level by 49.9 and 63.9%, respectively and 2 reduced the level by 31.2 and 44.4%, respectively. On the other hand, when the same doses were given intraperitoneally, both of compounds also exhibited a dose-dependent and more marked reduction of the serum uric acid level (% reduction at 20 and 50 mg/kg were 63.0 and 95.1% in 1, respectively and 66.9 and 86.5% in 2, respectively). Furthermore, the compounds 1 and 2 inhibited the rat liver xanthine oxidase activity with IC(50) values of 2.22 muM and 5.27 muM, respectively. These results demonstrated the hypouricemic action of 1 and 2, which may be attributable to their xanthine oxidase inhibitory activity.


Subject(s)
Esters/therapeutic use , Flavones/therapeutic use , Hyperuricemia/drug therapy , Quinic Acid/analogs & derivatives , Quinic Acid/therapeutic use , Uric Acid/antagonists & inhibitors , Administration, Oral , Allopurinol/pharmacology , Allopurinol/therapeutic use , Animals , Chrysanthemum , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Esters/pharmacology , Flavones/pharmacology , Hyperuricemia/chemically induced , Hyperuricemia/prevention & control , Inhibitory Concentration 50 , Injections, Intraperitoneal , Liver/chemistry , Liver/drug effects , Male , Oxonic Acid , Quinic Acid/pharmacology , Rats , Rats, Sprague-Dawley , Uric Acid/blood , Xanthine Oxidase/antagonists & inhibitors , Xanthine Oxidase/pharmacology , Xanthine Oxidase/therapeutic use
14.
Pharmacol Biochem Behav ; 82(2): 345-52, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16214209

ABSTRACT

The neuroprotective effects of Polygonum multiflorum extract (PME) and its two fractions, ethanol-soluble PME (PME-I) and -insoluble PME (PME-II), on the degeneration of nigrostriatal dopaminergic neurons induced by a combination of paraquat and maneb (PQMB) were investigated in male C57BL/6 mice. The mice were treated twice a week for 6 weeks with intraperitoneal injections of PQMB. This combination caused a reduction of spontaneous locomotor activity, motor incoordination, and declines of dopamine level in the striatum and tyrosine hydroxylase-positive neurons in the substantia nigra. Administration of PME and PME-I once daily for 47 days during 6 weeks of PQMB treatment and last 8 days after PQMB significantly attenuated the impairment of behavioral performance and the decrease in striatal dopamine level and substantia nigral tyrosine hydroxylase-positive neurons in the PQMB-treated animals, whereas the administration of PME-II had no effect on these behavioral, neurochemical and histological indices. The present findings suggest that PME has a beneficial influence on parkinsonism induced by PQMB and that the effects of PME are attributable to some substance(s) included in the ethanol-soluble fraction of PME (PME-I).


Subject(s)
Dopamine/physiology , Fungicides, Industrial/toxicity , Herbicides/toxicity , Maneb/toxicity , Neostriatum/pathology , Nerve Degeneration/pathology , Nerve Degeneration/prevention & control , Neuroprotective Agents/pharmacology , Paraquat/toxicity , Phytotherapy , Polygonum/chemistry , Substantia Nigra/pathology , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Antiparkinson Agents/therapeutic use , Chromatography, High Pressure Liquid , Dopamine/metabolism , Immunohistochemistry , Levodopa/therapeutic use , Male , Mice , Mice, Inbred C57BL , Motor Activity/drug effects , Nerve Degeneration/chemically induced , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/prevention & control , Plant Roots/chemistry , Tyrosine 3-Monooxygenase/metabolism
15.
Biol Pharm Bull ; 28(10): 1873-8, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16204938

ABSTRACT

We have previously shown using a water maze task that transient 2 vessel occlusion (T2VO) induced learning deficit in mice and that the deficit was prevented by pre-treatment of mice with chotosan, a Kampo prescription. In this study, we investigated the mechanism underlying the preventive effect of chotosan on T2VO-induced learning deficit. Chotosan administration 1 h before T2VO operation prevented learning impairment. The extract of Uncaria, a major constituent of chotosan, also had a protective effect on learning impairment in T2VO mice, whereas Uncaria-free chotosan had no beneficial effect on maze performance of T2VO mice. The ameliorative effect of chotosan was blocked by pirenzepine, a muscarinic M1 antagonist, but not by mecamylamine, a nicotinic receptor antagonist. Acetylcholine (ACh) content in the hippocampus of T2VO mice was significantly lower than that in the hippocampus of sham-operated control mice. Chotosan and Uncaria administration attenuated T2VO-induced reduction of ACh levels in the brain. These results suggest that the preventive effect of chotosan on transient ischemia-induced learning impairment is mainly attributable to the effect of Uncaria and that the ameliorative effect is mediated by stimulation of muscarinic M1 receptor.


Subject(s)
Brain Ischemia/prevention & control , Drugs, Chinese Herbal/pharmacology , Maze Learning/drug effects , Medicine, Kampo , Receptor, Muscarinic M1/agonists , Receptors, Muscarinic/drug effects , Acetylcholine/metabolism , Animals , Hippocampus/metabolism , Mice , Mice, Inbred ICR
16.
Biol Pharm Bull ; 28(8): 1389-93, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16079480

ABSTRACT

Stressors with a physical factor such as immobilization, electric foot shock, cold swim, etc., have been shown to produce oxidative damage to membrane lipids in the brain. In this study, we investigated the effect of protracted social isolation stress on lipid peroxidation activity in the mouse brain and elucidated the protective effect of majonoside-R2, a major saponin component of Vietnamese ginseng, in mice exposed to social isolation stress. Thiobarbituric acid reactive substance levels, one of the end products of lipid peroxidation reaction, were increased in the brains of mice subjected to 6-8 weeks of social isolation stress. Measurements of nitric oxide (NO) metabolites (NO(x)(-)) also revealed a significant increase of NO production in the brains of socially isolated mice. Moreover, the depletion of brain glutathione content, an endogenous antioxidant, in socially isolated animals occurred in association with the rise in lipid peroxidation. The intraperitoneal administration of majonoside-R2 (10-50 mg/kg) had no effect on thiobarbituric acid reactive substances (TBARS), NO, or glutathione levels in the brains of group-housed control mice but it significantly suppressed the increase in TBARS and NO levels and the decrease in glutathione levels caused by social isolation stress. These results suggest that mice subjected to 6-8 weeks of social isolation stress produces oxidative damage in the brain partly via enhancement of NO production, and that majonoside-R2 exerts a protective effect by modulating NO and glutathione systems in the brain.


Subject(s)
Brain/drug effects , Ginsenosides/pharmacology , Oxidative Stress , Panax/chemistry , Social Isolation , Stress, Psychological/prevention & control , Animals , Brain/metabolism , Ginsenosides/isolation & purification , Lipid Peroxidation , Male , Mice , Mice, Inbred ICR
17.
Pharmacol Biochem Behav ; 81(3): 616-25, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15936808

ABSTRACT

A recent double-blind and placebo-controlled study demonstrated a beneficial effect of Choto-san, a Kampo (traditional medicine of Japan) formula, on cognitive impairment in patients with vascular dementia. However, the neuronal mechanism underlying the therapeutic effects of this formula remains to be clarified. Using a chronic cerebral hypoperfusion model, we investigated the effect of Choto-san on cognitive dysfunction in mice to clarify its mechanism of actions. Chronic cerebral hypoperfusion was induced by permanent occlusion of both the common carotid arteries (2VO). Choto-san and Uncaria, a major constituent of Choto-san, caused an improvement in 2VO-induced learning deficits, whereas Uncaria-free Choto-san did not. The effects of Choto-san and Uncaria were blocked by pirenzepine, a selective muscarinic M1 antagonist. In a tube-dominance test, 2VO induced increased rates of assertive behavior in mice. 2VO mice administered Choto-san showed significantly reduced rates of assertive behavior compared to vehicle-treated controls, whereas Uncaria-free Choto-san and Uncaria had little effect on 2VO-induced assertive behavior. 2VO caused a significant decrease in the level of acetylcholine (ACh) contents in the brain, and the daily administration of Choto-san or Uncaria raised the ACh level to that in the sham-operated controls. These results suggest that Choto-san has an ameliorating effect on the spatial memory deficit caused by chronic hypoperfusion, and that the effect is mainly attributable to Uncaria. Moreover, it was suggested that the effects of Choto-san and Uncaria are at least partly mediated by stimulation of the muscarinic M1 receptor.


Subject(s)
Cerebral Cortex/blood supply , Drugs, Chinese Herbal/pharmacology , Learning Disabilities/prevention & control , Receptor, Muscarinic M1/physiology , Acetylcholine/metabolism , Aggression/drug effects , Alkaloids/pharmacology , Animals , Arterial Occlusive Diseases/complications , Avoidance Learning/drug effects , Behavior, Animal/drug effects , Carotid Artery, Common/pathology , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/therapeutic use , Hippocampus/drug effects , Hippocampus/metabolism , Learning Disabilities/etiology , Male , Maze Learning/drug effects , Medicine, Kampo , Mice , Mice, Inbred ICR , Muscarinic Antagonists/pharmacology , Phytotherapy , Pirenzepine/pharmacology , Reaction Time/drug effects , Uncaria/chemistry
18.
Eur J Pharmacol ; 517(3): 191-9, 2005 Jul 11.
Article in English | MEDLINE | ID: mdl-15963493

ABSTRACT

Isorhynchophylline is a major oxindole alkaloid found in Uncaria species which have long been used in traditional Chinese medicine. Here, we investigated the effects of isorhynchophylline and isorhynchophylline-related alkaloids on 5-hydroxytryptamine (5-HT) receptor-mediated behavioural responses in mice and 5-HT-evoked current responses in Xenopus oocytes expressing 5-HT2A or 5-HT2C receptors. Isorhynchophylline dose-dependently inhibited 5-HT2A receptor-mediated head-twitch but not 5-HT1A receptor-mediated head-weaving responses evoked by 5-methoxy-N,N-dimethyltryptamine. Pretreatment with reserpine, a monoamine-depleting agent, enhanced the head-twitching, but did not influence the effect of isorhynchophylline on the behavioural response. Isocorynoxeine, an isorhynchophylline-related alkaloid in which the configuration of the oxindole moiety is the same as in isorhynchophylline, also reduced the head-twitch response in reserpinized mice over the same dose range as isorhynchophylline, while both rhynchophylline and corynoxeine, stereoisomers of isorhynchophylline and isocorynoxeine, did not. None of the alkaloids tested had an effect on meta-chlorophenylpiperazine-induced hypolocomotion, a 5-HT2C receptor-mediated behavioural response. In experiments in vitro, isorhynchophylline and isocorynoxeine dose-dependently and competitively inhibited 5-HT-evoked currents in Xenopus oocytes expressing 5-HT2A receptors, but had less of a suppressive effect on those in oocytes expressing 5-HT2C receptors. These results indicate that isorhynchophylline and isocorynoxeine preferentially suppress 5-HT2A receptor function in the brain probably via a competitive antagonism at 5-HT2A receptor sites and that the configuration of the oxindole moiety of isorhynchophylline is essential for their antagonistic activity at the 5-HT2A receptor.


Subject(s)
Alkaloids/pharmacology , Brain/drug effects , Receptor, Serotonin, 5-HT2A/physiology , Aminopyridines/pharmacology , Animals , Behavior, Animal/drug effects , Brain/physiology , Dose-Response Relationship, Drug , Female , Indole Alkaloids , Ketanserin/pharmacology , Male , Membrane Potentials/drug effects , Methoxydimethyltryptamines/pharmacology , Mianserin/pharmacology , Mice , Mice, Inbred ICR , Motor Activity/drug effects , Oocytes/drug effects , Oocytes/physiology , Oxindoles , Patch-Clamp Techniques , Piperazines/pharmacology , Rats , Receptor, Serotonin, 5-HT2A/genetics , Receptor, Serotonin, 5-HT2C/genetics , Receptor, Serotonin, 5-HT2C/physiology , Serotonin/pharmacology , Serotonin 5-HT2 Receptor Antagonists , Serotonin Antagonists/pharmacology , Xenopus
19.
Biol Pharm Bull ; 28(4): 744-6, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15802822

ABSTRACT

Choto-san is a Kampo medicines that has been used clinically for the treatment of dementia. We measured the mRNA expressions of some factors related to Alzheimer's disease in a dementia model rat brain. The expressions of beta-amyloid precursor protein, gamma-secretase, alpha7 nicotinic acetylcholine receptor, neprilysin, and insulin degrading enzyme (IDE) were significantly increased on day 4 after permanent occlusion of the bilateral common carotid arteries (2VO). Choto-san inhibited the enhancement of IDE expression caused by 2VO, although it failed to show any effects on the expressions of the other molecules. These results suggest that Choto-san may produce a state in which it is not necessary to induce IDE expression to demonstrate the anti-dementia effects.


Subject(s)
Brain Ischemia/drug therapy , Brain Ischemia/metabolism , Drugs, Chinese Herbal/pharmacology , Gene Expression/drug effects , RNA, Messenger/metabolism , Alzheimer Disease/metabolism , Animals , Brain/metabolism , Gene Expression Profiling , Male , Medicine, Kampo , Rats , Rats, Wistar
20.
Biol Pharm Bull ; 28(1): 53-7, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15635163

ABSTRACT

We previously reported that Choto-san acts as an antioxidant and cytoprotective agents against H2O2-induced oxidative damage in NG108-15 cells, and the effect is due at least partly to the phenolic compounds. To further investigate the detail mechanisms of this cytoprotection effects of Choto-san and related compounds on enzyme activities of antioxidant systems were examined. Choto-san (5-100 microg/ml) and Chotoko (5-100 mg/ml) stimulated the activity of superoxide dismutase (SOD), catalase and glutathione peroxidase (GPX). These also increased the level of glutathione. Although Choto-san without Chotoko (w/o CKO) did not show the effects on SOD and catalase, GPX activity and glutathion content also, but weakly, stimulated by w/o CKO. The effects of phenolic compounds, epicatechin, caffeic acid and quercetin were also investigated. Epicatechin stimulated catalase, GPX and glutathion content, but not SOD. On the other hand, caffeic acid stimulated SOD activity but had no effects on others. Quercetin stimulated all, although intensities were different among. These results suggest that simultaneous induction of cellular antioxidant defense systems by Choto-sam and its related constituents may be an important mechanisms underlying the protective effects of Choto-san on ischemia-induced neuronal cells injury, and the characteristics of the stimulative effects of phenolic compounds were depend on enzymes.


Subject(s)
Antioxidants/metabolism , Drugs, Chinese Herbal/pharmacology , Cell Line , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Enzyme Activation/physiology , Humans , Superoxide Dismutase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...